The department of hemato oncology at BMCHRC is a hub of excellence committed to offering leading-edge care to patients suffering from a wide spectrum of hematological malignancies. Our team constantly strives to offer the best care to the patients while staying aligned with all the latest innovations and trends. We offer a wide range of leading-edge treatments under one roof, to give you a smooth and hassle-free experience. We have a team of nationally and internationally recognized hematologist and cancer specialists who work in close coordination to devise the best treatment plans for our patients. Our team will guide you on every step to give you on every step with the best medical advice, based on your overall health evaluation.

What is Hemato oncology?

Hemato oncology is a specialized branch of oncology that involves the application of clinical and experimental research in the field of hematology, which involves the study of blood, blood-forming organs and components like red blood cells, white blood cells, hemoglobin, blood protein and the mechanism of coagulation. Hemato oncology involves the detection, staging and management of the entire gamut of malignancies related to blood using specialized modalities and drugs that help to target and destroy cancer cells.

Conditions that are managed under our Department of Hemato Oncology:
  • Chronic leukemia’s- Chronic myeloid leukemia (CML), Essential thrombocytosis (ET), Myelofibrosis, Chronic lymphoid leukemia (CLL).
  • Acute leukemia-Acute lymphoblastic leukemia (ALL), Acute Myeloid Leukemia (AML).
  • Lymphomas- Hodgkin’s lymphoma, Non-Hodgkin’s lymphomas (NHL).
  • Plasma cell dyscrasias – Myeloma, Amyloidosis.
  • Anaemias- Nutritional, Autoimmune hemolytic anemias, Anemia of chronic disease.
  • Thalassemia, Sickle cell disease.
  • Thrombocytopenia- ITP (Immune thrombocytopenia).
  • Leucopenia, Leukocytosis, Eosinophilia.
  • Pancytopenia, Aplastic anemia, Myelodysplastic syndrome (MDS).
  • Polycythemia, Thrombocytosis.
  • Bleeding disorders- Hemophilia, Von Willebrand disease (VWD) and others.
  • Thrombotic disorders- Deep vein thrombosis (DVT), Cortical vein thrombosis (CVT), Pulmonary thromboembolism (PTE), and Abdominal vessel thrombosis.
  • Disseminated intravascular coagulation (DIC).
  • Pregnancy complications-Thrombocytopenia, Recurrent, pregnancy loss, Antiphospholipid antibody syndrome (APLA), Protein C & Protein S deficiency, DIC.
Areas of specialization

Our Hemato oncology team holds immense expertise in the management of the most complex cases with utmost proficiency. Our areas of specialization include:

  • Stem cell transplantation – Stem cell transplantation, also referred to as bone marrow transplant, is a highly specialized procedure that involves the infusion of healthy blood-forming stem cells into the body of a patient, to replace damaged bone marrow or stem cells. The healthy stem cells are either taken from a donor, or from the patient himself/herself. The former is referred to as an allogeneic stem cell transplant, whereas the latter is known as an autologous stem cell transplant. In the case of autologous transplant, the stem cells of the patient are collected prior to chemo or Radiation therapy, as these have the potential to destroy all the healthy cells. Once the procedure is done, the stem cells so collected, can be easily transferred back.
  • Chemotherapy – Chemotherapy involves the use of anti-cancer drugs that are given orally or intravenously to target malignant cells. This may contain a single medicine or a combination of two or more medicines that are to be given to the patient from time to time so as to target and kill the unhealthy cells. Patients who are recommended to undergo chemotherapy, often need a stem cell transplant to make up for the loss of healthy cells.
  • Radiation therapy – Radiation therapy is just like chemotherapy, the only difference being that instead of using drugs, radiation therapy involves the use of high-intensity radiations to target and kill the cancerous cells. The radiations may be given externally with the help of a special machine or internally, by placing radioactive material inside the patient’s body.